Literature DB >> 7091906

Serial changes in pulmonary functions in children hospitalized with cystic fibrosis.

G J Redding, R Restuccia, E K Cotton, J G Brooks.   

Abstract

Pulmonary functions were serially measured in 17 children hospitalized with cystic fibrosis (CF) to determine how much and when pulmonary functions improved during 14 days of inpatient treatment. Absolute lung volumes and forced expiratory flows were recorded every other day while patients received chest physiotherapy, antibiotics, and bronchodilators. Vital capacity first improved after the fifth hospital day coincidentally with a reduction in residual volume and an increase in peak expiratory flow rate. Significant improvements in other pulmonary functions developed later in the hospitalization. Improvement in most pulmonary functions continued throughout the hospitalization and was maintained 2 wk after discharge. Improvement was less and uniformly developed later in those children with severe lung disease on admission (NIH score less than 50) compared with those with moderate respiratory involvement (NIH score greater than 50). Pulmonary function measurements may prove useful in determining the optimal duration of treatment for patients who are hospitalized with CF.

Entities:  

Mesh:

Year:  1982        PMID: 7091906     DOI: 10.1164/arrd.1982.126.1.31

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes.

Authors:  J Michael Collaco; Deanna M Green; Garry R Cutting; Kathleen M Naughton; Peter J Mogayzel
Journal:  Am J Respir Crit Care Med       Date:  2010-06-25       Impact factor: 21.405

2.  Changes in Pulmonary Function and Controlled Ventilation-High Resolution CT of Chest After Antibiotic Therapy in Infants and Young Children with Cystic Fibrosis.

Authors:  Shahid I Sheikh; Frederick R Long; Robert Flucke; Nancy A Ryan-Wenger; Don Hayes; Karen S McCoy
Journal:  Lung       Date:  2015-03-12       Impact factor: 2.584

3.  Prevention of cross infection during outpatient spirometry.

Authors:  J Marchant; A Bush
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

4.  Two minute walking distance in cystic fibrosis.

Authors:  C J Upton; J C Tyrrell; E J Hiller
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

5.  Daily spirometry in an acute exacerbation of adult cystic fibrosis patients.

Authors:  Michael J Stephen; Alex Long; Chad Bonsall; Jeffrey B Hoag; Smita Shah; Dorothy Bisberg; Douglas Holsclaw; Laurie Varlotta; Stan Fiel; Doantrang Du; Robert Zanni; Denis Hadjiliadis
Journal:  Chron Respir Dis       Date:  2017-11-28       Impact factor: 2.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.